Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Journal of Gastroenterology
|
December 13, 2006
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis
Hiroto Kita, Yuichi Hikichi, Kouki Hikami, et al.
Molecular Cancer Therapeutics
|
May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency
Yuki Kamiyama, Takuro Sunada, Yutaka Kanoh, et al.
Cancer Medicine
|
February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
Tomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 4, 2018
[Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal Cancer]
Shoichiro Hikami, Atsushi Shiozaki, Hitoshi Fujiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 4, 2015
[A case of ARDS after esophagectomy treated with low-dose steroid therapy]
Shoichiro Hikami, Atsushi Shiozaki, Hitoshi Fujiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Resected Case of Intraperitoneal Foreign Body Granuloma Mimicking Peritoneal Dissemination]
Norio Itoh, Goshi Takayama, Gakushi Kitamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
March 3, 2016
[Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty]
Yuka Kono, Naoki Terada, Yasushi Takashima, et al.
The Prostate
|
May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate Cancer
Takuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
Molecular Cancer Therapeutics
|
December 23, 2011
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens
Yuichi Hikichi, Kohei Honda, Kouki Hikami, et al.
Arthritis Research & Therapy
|
September 23, 2008
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region
Aya Kawasaki, Ikue Ito, Koki Hikami, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Journal of Gastroenterology
|
December 13, 2006
Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis
Hiroto Kita, Yuichi Hikichi, Kouki Hikami, et al.
Molecular Cancer Therapeutics
|
May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiency
Yuki Kamiyama, Takuro Sunada, Yutaka Kanoh, et al.
Cancer Medicine
|
February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
Tomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 4, 2018
[Outcome of Patients with Pathological Complete Response after Neoadjuvant Chemotherapy in Advanced Esophageal Cancer]
Shoichiro Hikami, Atsushi Shiozaki, Hitoshi Fujiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
March 4, 2015
[A case of ARDS after esophagectomy treated with low-dose steroid therapy]
Shoichiro Hikami, Atsushi Shiozaki, Hitoshi Fujiwara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
February 2, 2024
[A Resected Case of Intraperitoneal Foreign Body Granuloma Mimicking Peritoneal Dissemination]
Norio Itoh, Goshi Takayama, Gakushi Kitamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica
|
March 3, 2016
[Advanced Adenocarcinoma of the Bladder after Augmentation Gastrocystoplasty]
Yuka Kono, Naoki Terada, Yasushi Takashima, et al.
The Prostate
|
May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate Cancer
Takuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
Molecular Cancer Therapeutics
|
December 23, 2011
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens
Yuichi Hikichi, Kohei Honda, Kouki Hikami, et al.
Arthritis Research & Therapy
|
September 23, 2008
Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region
Aya Kawasaki, Ikue Ito, Koki Hikami, et al.
Page
of 6